SCHEMBL30142663

SCHEMBL30142663

CCCCNc1ccc(C(=O)Nc2ncc(Br)s2)c(-c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 2/20 0.47
▸ F2R P25116 2/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ POLQ O75417 3/20 0.40
▸ CSNK2A2 P19784 1/20 0.40
▸ CSNK2B P67870 1/20 0.40
▸ CSNK2A1 P68400 1/20 0.40
▸ CSNK2A3 Q8NEV1 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ KDR P35968 1/20 0.38
▸ STIM1 Q13586 1/20 0.38
▸ ORAI1 Q96D31 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24074004 1.00 FBP1 (0.47) FBP1F2RMAPK10SMN1; SMN2CCNE1
SCHEMBL30142800 0.89 KDR (0.52) F2RCCNE1CDK2CDK5POLQ
SCHEMBL24074003 0.89 KDR (0.52) F2RCCNE1CDK2CDK5POLQ
SCHEMBL24074165 0.89 ALDH1A1 (0.48) F2RSMN1; SMN2POLQLMNAMEN1
SCHEMBL30142748 0.89 PRSS12 (0.44) F2RPOLQALOX15KDR
SCHEMBL24074006 0.88 F2R (0.41) F2RPOLQALOX15KDRSTIM1
SCHEMBL30142807 0.88 F2R (0.41) F2RPOLQALOX15KDRSTIM1
SCHEMBL24074000 0.87 F2R (0.41) F2RCCNE1CDK2CDK5POLQ
SCHEMBL24074014 0.86 F2R (0.40) F2RPOLQLMNAALOX15KDR
SCHEMBL30142767 0.86 F2R (0.40) F2RPOLQLMNAALOX15KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 — — CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 — — EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 FBP1 2489/4885F2R 1930/4885MAPK10 3330/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 FBP1 2489/4885F2R 1930/4885MAPK10 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback